CU Lymphoma Program (@culymphoma) 's Twitter Profile
CU Lymphoma Program

@culymphoma

The official account for the @CUMedicalSchool @CUAnschutz Lymphoma Program. #lymsm

ID: 1570480891587182594

linkhttps://medschool.cuanschutz.edu/hematology/faculty-by-name/home/providers calendar_today15-09-2022 18:33:24

329 Tweet

271 Followers

203 Following

CU Lymphoma Program (@culymphoma) 's Twitter Profile Photo
CU Lymphoma Program
@culymphoma

3 months ago

We're excited to open the phase 3 randomized trial of sonrotoclax/zanubrutinib versus venetoclax/obinutuzumab in untreated CLL/SLL at CU Anschutz Medical Campus. Learn more at our CU Anschutz Division of Hematology clinical trials page below. cc manalikamdar #lymsm medschool.cuanschutz.edu/hematology/all…

We're excited to open the phase 3 randomized trial of sonrotoclax/zanubrutinib versus venetoclax/obinutuzumab in untreated CLL/SLL at <a href="/CUAnschutz/">CU Anschutz Medical Campus</a>. Learn more at our <a href="/CUHematology/">CU Anschutz Division of Hematology</a> clinical trials page below. cc <a href="/mana1981/">manalikamdar</a> #lymsm medschool.cuanschutz.edu/hematology/all…